Literature DB >> 8747103

Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study.

C E Kashtan1, P T McEnery, A Tejani, D M Stablein.   

Abstract

The data base of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) was used to examine the effect of primary diagnosis on the outcome of renal transplantation in children. The relative risk of graft failure for eight diagnostic groups was determined, with patients with congenital and structural anomalies of the urinary tract serving as the reference group. Covariate analysis was used to control for the effects of age, race and transfusion history in recipients of living-related donor kidneys, and for age, donor age, antilymphocyte prophylaxis, prior transplantation, prior dialysis and cold ischemia time in recipients of cadaver kidneys. In recipients of living-related donor kidneys, the lowest graft failure rates were associated with the diagnoses of cystinosis, familial nephritis and hemolytic uremic syndrome (HUS), while the highest failure rates were observed in patients with a primary diagnosis of congenital nephrotic syndrome (CNS) or focal segmental glomerulosclerosis (FSGS). In cadaver allograft recipients, the lowest graft failure rates were associated with primary diagnoses of glomerulonephritis, congenital/structural disease and cystinosis, while patients with FSGS, HUS and CNS had the highest graft failure rates. This study suggests that patients with a primary diagnosis of cystinosis have superior outcomes, while the diagnoses of FSGS and CNS carry with them the highest risks of graft failure.

Entities:  

Mesh:

Year:  1995        PMID: 8747103     DOI: 10.1007/bf00868709

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis.

Authors:  E Stephanian; A J Matas; S M Mauer; B Chavers; T Nevins; C Kashtan; D E Sutherland; P Gores; J S Najarian
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

2.  Should women who are known or potential carriers of the Alport gene be accepted as kidney donors?

Authors:  C E Kashtan
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

3.  Recurrence of hemolytic uremic syndrome in renal transplant recipients.

Authors:  D Hebert; R K Sibley; S M Mauer
Journal:  Kidney Int Suppl       Date:  1986-07       Impact factor: 10.545

Review 4.  Alport syndrome: from bedside to genome to bedside.

Authors:  C E Kashtan; A F Michael
Journal:  Am J Kidney Dis       Date:  1993-11       Impact factor: 8.860

5.  Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

Authors:  D Hébert; E M Kim; R K Sibley; M S Mauer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood.

Authors:  M M Fitzpatrick; M D Walters; R S Trompeter; M J Dillon; T M Barratt
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

7.  Renal transplantation in 22 children with nephropathic cystinosis.

Authors:  J H Ehrich; J Brodehl; D I Byrd; S Hossfeld; P F Hoyer; K P Leipert; G Offner; G Wolff
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

8.  Renal transplantation in patients with classical haemolytic-uraemic syndrome.

Authors:  C E Bassani; J Ferraris; C A Gianantonio; S Ruiz; J Ramirez
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

9.  Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  A Tejani; D H Stablein
Journal:  J Am Soc Nephrol       Date:  1992-06       Impact factor: 10.121

10.  Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases.

Authors:  R W Watts; S H Morgan; C J Danpure; P Purkiss; R Y Calne; K Rolles; L R Baker; M A Mansell; L H Smith; R M Merion
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

View more
  15 in total

Review 1.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

2.  Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children.

Authors:  A D Schachter; W E Harmon
Journal:  Pediatr Transplant       Date:  2001-12

3.  Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.

Authors:  Johanna Temme; Anneke Kramer; Kitty J Jager; Katharina Lange; Frederick Peters; Gerhard-Anton Müller; Reinhard Kramar; James G Heaf; Patrik Finne; Runolfur Palsson; Anna V Reisæter; Andries J Hoitsma; Wendy Metcalfe; Maurizio Postorino; Oscar Zurriaga; Julio P Santos; Pietro Ravani; Faical Jarraya; Enrico Verrina; Friedo W Dekker; Oliver Gross
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

Review 4.  Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.

Authors:  Yasar Caliskan; Krista L Lentine
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.651

Review 5.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

Review 6.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08

Review 7.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

Review 8.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 9.  Cystinosis: practical tools for diagnosis and treatment.

Authors:  Martijn J Wilmer; Joost P Schoeber; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

10.  CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Authors:  Laura H Mariani; Andrew S Bomback; Pietro A Canetta; Michael F Flessner; Margaret Helmuth; Michelle A Hladunewich; Jonathan J Hogan; Krzysztof Kiryluk; Patrick H Nachman; Cynthia C Nast; Michelle N Rheault; Dana V Rizk; Howard Trachtman; Scott E Wenderfer; Corinna Bowers; Peg Hill-Callahan; Maddalena Marasa; Caroline J Poulton; Adelaide Revell; Suzanne Vento; Laura Barisoni; Dan Cattran; Vivette D'Agati; J Charles Jennette; Jon B Klein; Louis-Philippe Laurin; Katherine Twombley; Ronald J Falk; Ali G Gharavi; Brenda W Gillespie; Debbie S Gipson; Larry A Greenbaum; Lawrence B Holzman; Matthias Kretzler; Bruce Robinson; William E Smoyer; Lisa M Guay-Woodford
Journal:  Am J Kidney Dis       Date:  2018-11-09       Impact factor: 11.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.